FR2220265A1 - - Google Patents

Info

Publication number
FR2220265A1
FR2220265A1 FR7407621A FR7407621A FR2220265A1 FR 2220265 A1 FR2220265 A1 FR 2220265A1 FR 7407621 A FR7407621 A FR 7407621A FR 7407621 A FR7407621 A FR 7407621A FR 2220265 A1 FR2220265 A1 FR 2220265A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7407621A
Other languages
French (fr)
Other versions
FR2220265B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of FR2220265A1 publication Critical patent/FR2220265A1/fr
Application granted granted Critical
Publication of FR2220265B1 publication Critical patent/FR2220265B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7407621A 1973-03-07 1974-03-06 Expired FR2220265B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1101873A GB1417029A (en) 1973-03-07 1973-03-07 Quinazoline-derived amines

Publications (2)

Publication Number Publication Date
FR2220265A1 true FR2220265A1 (en) 1974-10-04
FR2220265B1 FR2220265B1 (en) 1977-11-10

Family

ID=9978541

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7407621A Expired FR2220265B1 (en) 1973-03-07 1974-03-06

Country Status (9)

Country Link
JP (1) JPS5029582A (en)
BE (1) BE811856A (en)
DE (1) DE2410938A1 (en)
DK (1) DK132892C (en)
FR (1) FR2220265B1 (en)
GB (1) GB1417029A (en)
IE (1) IE39546B1 (en)
LU (1) LU69561A1 (en)
NL (1) NL7403075A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001422A (en) * 1974-07-25 1977-01-04 Pfizer Inc. 4-aminoquinazoline cardiac stimulants
WO2007030582A2 (en) * 2005-09-09 2007-03-15 Bristol-Myers Squibb Company Acyclic ikur inhibitors

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52126939A (en) * 1976-04-19 1977-10-25 Stanley Electric Co Ltd Method of filtering regenerative drain water treating device
IT1229237B (en) * 1989-05-08 1991-07-26 Prodotti Formenti SALTS OF (2- (PYRIDYL) ETHYL) METHYLAMINE
WO1995007267A1 (en) * 1993-09-10 1995-03-16 Eisai Co., Ltd. Quinazoline compound
IL112248A0 (en) 1994-01-25 1995-03-30 Warner Lambert Co Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
HU219864B (en) 1994-08-09 2001-08-28 Eisai Co., Ltd. Cgmp-pde inhibitory fused pyridazine derivatives and use thereof
DE69919707T2 (en) 1998-06-19 2005-09-01 Chiron Corp., Emeryville GLYCOGEN SYNTHASE KINASE 3 INHIBITORS
CA2493004A1 (en) * 2002-07-17 2004-01-22 Lek Pharmaceuticals D.D. Novel derivatives of pyridylethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, processes for their preparation, and pharmaceutical compositions containing them
EP2014662A1 (en) * 2007-07-12 2009-01-14 Bayer Schering Pharma Aktiengesellschaft Indolyl alkyl thieno-pyrimidyl amines as modulators of EP2 receptors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001422A (en) * 1974-07-25 1977-01-04 Pfizer Inc. 4-aminoquinazoline cardiac stimulants
WO2007030582A2 (en) * 2005-09-09 2007-03-15 Bristol-Myers Squibb Company Acyclic ikur inhibitors
WO2007030582A3 (en) * 2005-09-09 2007-06-14 Bristol Myers Squibb Co Acyclic ikur inhibitors
US7915410B2 (en) 2005-09-09 2011-03-29 Bristol-Myers Squibb Company Acyclic IKur inhibitors
US8357809B2 (en) 2005-09-09 2013-01-22 Bristol-Myers Squibb Company Acyclic IKur inhibitors

Also Published As

Publication number Publication date
GB1417029A (en) 1975-12-10
IE39546L (en) 1974-09-07
BE811856A (en) 1974-09-04
FR2220265B1 (en) 1977-11-10
DE2410938A1 (en) 1974-09-19
LU69561A1 (en) 1976-02-04
DK132892C (en) 1976-07-19
IE39546B1 (en) 1978-11-08
DK132892B (en) 1976-02-23
JPS5029582A (en) 1975-03-25
NL7403075A (en) 1974-09-10

Similar Documents

Publication Publication Date Title
AU476761B2 (en)
AU465372B2 (en)
AU474593B2 (en)
AU474511B2 (en)
AU474838B2 (en)
AU471343B2 (en)
AU465453B2 (en)
AU465434B2 (en)
AU450229B2 (en)
AU476714B2 (en)
FR2220265B1 (en)
AU466283B2 (en)
AU472848B2 (en)
AU476696B2 (en)
AU477823B2 (en)
AU477824B2 (en)
AU471461B2 (en)
AU461342B2 (en)
AU447540B2 (en)
AU476873B1 (en)
AU1891376A (en)
CH1183573A4 (en)
AU479562A (en)
AU479420A (en)
AU479419A (en)

Legal Events

Date Code Title Description
ST Notification of lapse